SB-216477
N/A
Report date: 2025/06/11 20:01:15
NME
Base Information
Drug NameSB-216477
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A